Starna offers new photometric linearity reference sets

Published: 13-May-2010

Suitable for pharmaceutical QA laboratories

Starna Scientific’s near infrared (NIR) traceable photometric linearity reference sets are now available for pharmaceutical QA labs and customer support organisations seeking to qualify their NIR systems. These reference sets offer Operational Qualification (OQ) and Performance Qualification (PQ) of the transmittance scale in the NIR using industry standard protocols.

The sets are based on easy to handle, non-consumable Certified Reference Materials for qualifying the NIR Transmittance scale. The wavelength range covered is 1100 to 2850nm, with a %T (A) range of 1.5 %T (1.82A) to 61%T (0.21A).

Starna, based in Hainault, Essex, UK, has many years of experience gained preparing Visible Neutral Density filter references for ISO 17025 and ISO Guide 34 accreditation and produces references for National Measurement Institutions (NMIs).

See more

You may also like

Cell & Gene Therapy

Algen Biotechnologies partners with AstraZeneca in $555m deal to advance AI-driven drug discovery in immunology

Read more
Algen Biotechnologies has entered a multi-target partnership with AstraZeneca to leverage its AI-powered AlgenBrain platform for identifying novel therapeutic targets in immunology, with the collaboration aimed at accelerating next-generation treatment discovery

Trending Articles

  1. Agility, scale and trust: the outsourcing model driving pharma forward Outsourcing in the pharmaceutical industry has long been viewed as a matter of convenience and a way to ease short-term capacity pressures or delay the decision to invest in costly new facilities. That framing no longer fits
  2. RION engages Lonza to scale manufacturing exosome based therapeutics Collaboration leverages RION’s proprietary biomanufacturing process to propel RION’s industry-leading clinical development pipeline towards late-phase trials and commercialisation for multiple regenerative medical conditions
  3. Merck and others pull back from UK: what it means for pharma manufacturing With pharma giant Merck pulling its own version of Brexit, what can the UK do to retain its drug manufacturing capabilities?
  4. Genmab to acquire Merus in $8bn deal to expand late-stage pipeline The acquisition adds breakthrough therapy petosemtamab to Genmab’s portfolio, accelerating its shift to a wholly owned model and supporting multiple new drug launches by 2027
  5. Gerresheimer boosts Wertheim site with new production facility The new production hall will focus on RTF vials and innovative EZ-fill Smart packaging platform, with a total investment volume of around EUR €30 million

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Cell & Gene Therapy

Algen Biotechnologies partners with AstraZeneca in $555m deal to advance AI-driven drug discovery in immunology

Algen Biotechnologies has entered a multi-target partnership with AstraZeneca to leverage its AI-powered AlgenBrain platform for identifying novel therapeutic targets in immunology, with the collaboration aimed at accelerating next-generation treatment discovery
Analysis

Global biopharma faces talent shortages and regulatory uncertainty, Cytiva’s 2025 Global Biopharma Index finds

Cytiva’s latest Global Biopharma Index, surveying 1250 executives across 22 countries, reveals that while supply chain resilience is improving, talent shortages and policy instability are threatening growth across the biopharma sector
Microbiology

Boehringer Ingelheim and MOLCURE partner to accelerate AI-driven antibody discovery

Boehringer Ingelheim has entered a multi-year research agreement with MOLCURE to develop next-generation antibody therapeutics using MOLCURE's proprietary AI platform, combining machine learning and experimental data to streamline and enhance drug discovery
Manufacturing

Rentschler Biopharma expands services in Japan and South Korea ahead of BioProcess International Asia

Rentschler Biopharma will showcase its Rentschler Expression Platform and Development Services at BioProcess International Asia in Kyoto, underscoring its commitment to supporting biopharma partners across Japan and South Korea
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Decoding your personal health ecosystem: the power of microbiome diagnostics and nutraceuticals

People often talk about a “gut instinct” or a “gut feeling.” Until recently, though, actually discussing digestive health might have seemed unusual, suggests Christina Casén, Senior Vice President, Clinical and Medical Affairs at Genetic Analysis AS
Hi Tech Manufacturing

A new era in rheometry with Anton Paar’s next-generation MCR series

Building on its industry-leading legacy in rheometry, Anton Paar has unveiled its next generation of modular compact rheometers (MCRs), setting new benchmarks for precision, speed, intelligence, and adaptability in material characterisation
Manufacturing

Navigating SOE compliance: how to strengthen organic enforcement within your organisation

Part I of NSF’s webinar series explores strategies to meet rising regulatory demands, reduce fraud, and promote ethical practices
Subscribe now